LUSTRI, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 183
EU - Europa 35
AS - Asia 16
Totale 234
Nazione #
US - Stati Uniti d'America 182
IT - Italia 17
IN - India 9
FI - Finlandia 5
SE - Svezia 5
CN - Cina 4
SG - Singapore 3
DE - Germania 2
FR - Francia 2
CA - Canada 1
EE - Estonia 1
IE - Irlanda 1
NL - Olanda 1
RO - Romania 1
Totale 234
Città #
Fairfield 40
Ashburn 19
Cambridge 15
Woodbridge 15
Houston 13
Seattle 12
Wilmington 11
Rome 8
Plano 5
Ann Arbor 4
Princeton 4
Santa Clara 4
Alpharetta 3
Dearborn 3
Fremont 3
San Diego 3
Beijing 2
Boston 2
Singapore 2
Atlanta 1
Catania 1
Dublin 1
Falkenstein 1
Helsinki 1
Kunming 1
Lawrence 1
Milan 1
Munich 1
Stockholm 1
Tallinn 1
Toronto 1
Totale 180
Nome #
Sensitivity of human intrahepatic cholangiocarcinoma subtypes to chemotherapeutics and molecular targeted agents: A study on primary cell cultures 69
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA) 66
Microgravity maintains stemness and enhance glycolytic metabolism in human hepatic and biliary tree stem/progenitor cells 58
The Niche-Derived Glial Cell Line-Derived Neurotrophic Factor (GDNF) Induces Migration of Mouse Spermatogonial Stem/Progenitor Cells 54
OC.13.3: Metformin Inhibits Proliferation, Enhances Apoptosis and Down-Regulates Epithelial to Mesenchymal Transition (EMT) in Human Cholangiocarcinoma (CCA): A Study on Human Primary Cell Cultures 12
P.10.4: The Differentiation and Metabolism of Human Hepatic and Biliary Tree Stem/Progenitor Cells can be Significantly Modulated by Microgravity 3
Totale 262
Categoria #
all - tutte 506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 10 11 7 7 5 2 5
2020/202117 3 2 0 2 0 4 3 1 1 0 1 0
2021/202244 0 2 2 1 8 0 1 5 3 3 12 7
2022/202311 7 1 0 1 0 0 1 0 1 0 0 0
2023/20247 1 1 0 2 2 0 0 0 0 0 1 0
2024/202531 0 1 0 0 23 7 0 0 0 0 0 0
Totale 262